Evidence map›Paper›PMID 32415792›Full record

Trial reportBritish journal of haematology2020

Low educational level of head of household, as a proxy for poverty, is associated with severe anaemia among children with sickle cell disease living in a low-resource setting: evidence from the SPRING trial.

Halima Bello-Manga, Aisha A Galadanci, Shehu Abdullahi, Shehi Ali, Binta Jibir, Safiya Gambo, Lawal Haliru, Lori C Jordan, Muktar H Aliyu, Mark Rodeghier and 3 more

Open access · bronzeAbstract readClinical Trial, Phase IIIMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in British journal of haematology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Hydroxyurea (hydroxycarbamide) for sickle cell disease.The Cochrane database of systematic reviews · 2022
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Halima Bello-MangaDepartment of Hematology and Blood Transfusion, Barau Dikko Teaching Hospital/Kaduna State University, Kaduna, Nigeria.ORCID 0000-0001-9993-4548
Aisha A GaladanciDepartment of Hematology and Blood Transfusion, Aminu Kano Teaching Hospital/Bayero University, Kano, Nigeria.
Shehu AbdullahiDepartment of Pediatrics, Aminu Kano Teaching Hospital/Bayero University, Kano, Nigeria.
Shehi AliDepartment of Radiology, Aminu Kano Teaching Hospital/Bayero University, Kano, Nigeria.
Binta JibirDepartment of Pediatrics, Hasiya Bayero Children's Hospital, Kano, Nigeria.
Safiya GamboDepartment of Pediatrics, Murtala Muhammad Specialist Hospital Kano, Kano, Nigeria.
Lawal HaliruDepartment of Pediatrics, Barau Dikko Teaching Hospital/Kaduna State University, Kaduna, Nigeria.
Lori C JordanDepartment of Pediatrics, Division of Pediatric Neurology, Vanderbilt University of Medicine, Nashville, TN, USA.
Muktar H AliyuFamily Medicine/Preventive Medicine, Vanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, TN, USA.
Mark RodeghierRodeghier Consulting, Chicago, IL, USA.
Adetola A KassimDepartment of Medicine, Division of Hematology/Oncology, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, TN, USA.
Michael R DeBaunDepartment of Pediatrics, Division of Hematology-Oncology, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, TN, USA.
Najibah A GaladanciDepartment of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA.
Aminu Kano Teaching Hospital · NGVanderbilt University Medical Center · USKaduna State University · NGBayero University Kano · NGHarbage Consulting · USUniversity of Alabama at Birmingham · USVanderbilt University · US

Funding

Primary prevention of stroke in children with SCD in Sub-Saharan Africa IIR01NS094041 · NINDS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ABDULLAHI, SHEHU UMAR, ALIYU, MUKTAR HASSAN · 2015 to 2019
$5.4M
Mentoring in Patient-Oriented Research focused on Neurological Complications of Sickle Cell DiseaseK24HL147017 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI JORDAN, LORI CHAFFIN · 2019 to 2023
$547k
NHLBI NIH HHS K24 HL147017NIH HHS 1R01NS094041NINDS NIH HHS R01 NS094041
6 · The paper itself

Abstract

Severe anaemia, defined as haemoglobin level < 6·0 g/dl, is an independent risk factor for death in individuals with sickle cell disease living in resource-limited settings. We conducted a cross-sectional study of 941 children with sickle cell anaemia, who had been defined as phenotype HbSS or HbSβ

Indexed as

Educational StatusFamily CharacteristicsPovertyAdultAnemia, Sickle CellChildChild, PreschoolCross-Sectional StudiesFemaleHumansMaleNigeriaStrokeThalassemiasevere anaemiasickle cell diseasesub-Saharan Africa

Identifiers

PMID32415792
PMCPMC7669582
OpenAlexW3024501209

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.